SMS Pharmaceuticals has informed that it has enclosed the annual disclosure under Regulation 3 1(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011 from Promoters of the Company dated May 27 , 2020 , for the financial year ended on March 31 , 2020.
The above information is a part of company’s filings submitted to BSE.